Nitin Sood
Plus aucun poste en cours
Fortune : 777 605 $ au 30/06/2024
Profil
Nitin Sood formerly worked at Tecan Genomics, Inc., as Chief Executive Officer & Director, Boreal Genomics, Inc., as Chief Executive Officer from 2011 to 2013, Agilent Technologies, Inc., as General Manager-Automation & Electrophoresis Units, and Adaptive Biotechnologies Corp., as Chief Commercial Officer-MRD from 2022 to 2023.
Mr. Sood received his graduate degree from Ball State University (Indiana) and graduate degree from the University of Delhi.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/08/2023 | 214 808 ( 0,15% ) | 777 605 $ | 30/06/2024 |
Anciens postes connus de Nitin Sood
| Sociétés | Poste | Fin |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Corporate Officer/Principal | 28/07/2023 |
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Tecan Genomics, Inc.
 Tecan Genomics, Inc. Electronic Equipment/InstrumentsElectronic Technology Tecan Genomics, Inc. provides genomics sample preparation solutions. It offers solutions which make biological samples accessible for genomic analysis. The firm has commercialized numerous proprietary DNA and RNA sample preparation products for use in research and diagnostic applications. The company was founded by Jan D'Alvise, James W. Larrick and Nurith Kurn in 2000 and is headquartered in San Carlos, CA. | Directeur Général | - |
Boreal Genomics, Inc.
 Boreal Genomics, Inc. Medical SpecialtiesHealth Technology Boreal Genomics, Inc. develops and markets DNA and RNA purification, enrichment, and detection equipment and tools. It provides research tools and developing diagnostic tests based on non invasive tumor profiling and monitoring of cancer. The company’s OnTarget platform performs sensitive genomic analysis of cell free DNA in plasma to detect and quantify mutations in tumor derived circulating nucleic acids. The company was founded by Andre Marziali, Jason Donald Thompson, Joel Pel and David J. Broemeling in 2007 and is headquartered in Vancouver, Canada. | Directeur Général | - |
Formation de Nitin Sood
| Ball State University (Indiana) | Graduate Degree |
| University of Delhi | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AGILENT TECHNOLOGIES, INC. | Commercial Services |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
Boreal Genomics, Inc.
Boreal Genomics, Inc. Medical SpecialtiesHealth Technology Boreal Genomics, Inc. develops and markets DNA and RNA purification, enrichment, and detection equipment and tools. It provides research tools and developing diagnostic tests based on non invasive tumor profiling and monitoring of cancer. The company’s OnTarget platform performs sensitive genomic analysis of cell free DNA in plasma to detect and quantify mutations in tumor derived circulating nucleic acids. The company was founded by Andre Marziali, Jason Donald Thompson, Joel Pel and David J. Broemeling in 2007 and is headquartered in Vancouver, Canada. | Health Technology |
Tecan Genomics, Inc.
Tecan Genomics, Inc. Electronic Equipment/InstrumentsElectronic Technology Tecan Genomics, Inc. provides genomics sample preparation solutions. It offers solutions which make biological samples accessible for genomic analysis. The firm has commercialized numerous proprietary DNA and RNA sample preparation products for use in research and diagnostic applications. The company was founded by Jan D'Alvise, James W. Larrick and Nurith Kurn in 2000 and is headquartered in San Carlos, CA. | Electronic Technology |
